Risperdal Consta and Health Care Utilization in Patients With Schizophrenia
Information source: Emory University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Schizophrenia; Schizoaffective Disorder
Intervention: Risperdal Consta (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Emory University Official(s) and/or principal investigator(s):
Dragana Bugarski-Kirola, MD, Principal Investigator, Affiliation: Emory University
Summary
The purpose of this study is to determine if Risperdal Consta will affect the healthcare
utilization costs in chronically ill schizophrenic patients with multiple admissions to the
psychiatric hospital compared to the previous utilization costs under standard oral
treatment of any atypical antipsychotic. We hypothesize that higher Risperdal Consta
acquisition costs can be offset by reduction in total medical utilization costs, such as
hospitalizations, ER visits, unscheduled outpatient visits or incarcerations due to
worsening of psychotic symptoms.
Clinical Details
Official title: The Effects of Risperdal Consta on Health Care Utilization Costs in Chronically Ill Schizophrenic Patients
Study design: Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label
Eligibility
Minimum age: 18 Years.
Maximum age: 55 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Primary diagnosis of schizophrenia or schizoaffective disorder
- 4 or more admissions to psychiatric hospital in past year, OR minimum of 2 hospital
admissions and at least 2 incarcerations in the previous year
- Medicaid recipient
- Patients requiring concomitant non-antipsychotic psychotropic medication (mood
stabilizing, antidepressants, anxiolytics)
Exclusion Criteria:
- Past or current psychiatric disorder, other than schizophrenia or schizoaffective
disorder
- Drug or alcohol dependence
- Serious, unstable medical illness or any acute medical condition
- Pregnant or lactating females
- Prior Risperdal Consta treatment
- Non-English speaking
Locations and Contacts
Grady Hospital, Atlanta, Georgia, United States
Additional Information
Starting date: December 2005
Last updated: September 23, 2014
|
